LncRNA HAS2-AS1 Promotes Glioblastoma Proliferation by Sponging miR-137Yalin Lu, Qiang Huang, Zhimeng Zhang et al.|Frontiers in Oncology|2021Cited by 33
CO-STAR: Surgical conversion feasibility trial of sintilimab (PD-1 inhibitor) combined with Nab-PTX, S-1 and apatinib for the first-line treatment of stage IV gastric cancer (GC).Qiang Xue, Han Liang, Baogui Wang et al.|Journal of Clinical Oncology|2021Cited by 6
Lymphodepletion-free jl-lightning CAR-T targeting CD19/CD22/BCMA achieved 100% CR in 3 Relapsed/Refractory B-NHL patients: A lymphodepletion regimen comparison studyJinxing Lou, Qijun Qian, Yan Sun et al.|Blood|2025Cited by 0